Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    miksad
Show Display Options
Rank Status Study
1 Active, not recruiting Capecitabine and Oxaliplatin in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma
Condition: Pancreatic Cancer
Interventions: Drug: Capecitabine;   Drug: Oxaliplatin
2 Active, not recruiting Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancer
Condition: Hepatocellular Cancer
Interventions: Drug: Sorafenib;   Procedure: Radiofrequency Ablation
3 Not yet recruiting A Phase II Study of Pembrolizumab in Refractory Advanced Esophageal Cancer
Conditions: Esophageal Cancer;   Squamous Cell Esophagus Cancer;   Adenocarcinoma Esophagus
Intervention: Drug: Pembrolizumab
4 Recruiting Study of Vitamin D in Untreated Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Interventions: Drug: FOLFOX + bevacizumab;   Dietary Supplement: Vitamin D

Study has passed its completion date and status has not been verified in more than two years.